Publicado 6 números por año
ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472
Indexed in
The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins
SINOPSIS
The bacterial enterotoxins, cholera toxin and the heat labile toxin of E. coli, are well known adjuvants for mucosal immune response. Their common A chain mediates the toxigenic mechanism by causing ADP ribosylation of G proteins and subsequent elevation of cAMP in target cells. A large IgA and IgG antibody response to admixed protein antigen (Ag) is the hallmark of these adjuvants and is clearly associated with the A chain activity. Expansion of Ag-specific B and T cells, alteration of T cell cytokine production, and changes in regulatory T cells have been reported as adjuvant mechanisms. The B chain derivatives of these toxins can also weakly enhance immune response, especially if covalently associated with Ag and used for nasophyrangeal immunization. Importantly, these toxins or their B chain derivatives can alter the normal immune regulation that produces oral tolerance. This indicates that they modulate mechanisms operative between the mucosal and systemic immune systems. There are some discrepancies between in vitro models of CT or LT activity and in vivo manifestations of their adjuvant activities. Interpretation of current data regarding in vivo mechanism is hampered by an incomplete understanding of how mucosal B and T cells can interact with systemic lymphoid tissue and vice versa. More important, there is no clear understanding of the early effects of the toxins on the local (and draining) mucosal lymphoid tissues. This is especially true in the critical areas of antigen presentation, T and B cell activation, and cytokine production.
-
Lycke Nils, Recent progress in mucosal vaccine development: potential and limitations, Nature Reviews Immunology, 12, 8, 2012. Crossref
-
Bao Wen-bin, Ye Lan, Zi Chen, Liu Lu, Zhu Jing, Pan Zhang-yuan, Zhu Guo-qiang, Huang Xue-gen, Wu Sheng-long, Relationship between the expression level of SLA-DQA and Escherichia coli F18 infection in piglets, Gene, 494, 1, 2012. Crossref
-
de Haan Lolke, Verweij Willem, Agsteribbe Etienne, Wilschut Jan, The role of ADP-ribosylation and GM1-binding activity in the mucosal immunogenicity and adjuvanticity of theEscherichia coliheat-labile enterotoxin andVibrio choleraecholera toxin, Immunology and Cell Biology, 76, 3, 1998. Crossref
-
Millar Douglas G., Hirst Timothy R., Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments, Cellular Microbiology, 3, 5, 2001. Crossref
-
Russell Michael W., Wu Hong-Yin, Hajishengallis George, Hollingshead Susan K., Michalek Suzanne M., Cholera Toxin B Subunit as an Immunomodulator for Mucosal Vaccine Delivery, in Veterinary Vaccines and Diagnostics, 41, 1999. Crossref
-
DE HAAN L., VERWEIJ W. R., FEIL I. K., HOLTROP M., HOL W. G. J., AGSTERIBBE E., WILSCHUT J., Role of GM1binding in the mucosal immunogenicity and adjuvant activity of theEscherichia coliheat‐labile enterotoxin and its B subunit, Immunology, 94, 3, 1998. Crossref
-
BenMohamed Lbachir, Krishnan Radhika, Auge Catherine, Primus James F., Diamond Don J., Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses, Immunology, 106, 1, 2002. Crossref
-
De Haan , Holtrop , Verweij , Agsteribbe , Wilschut , Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of theEscherichia coliheat-labile enterotoxin, Immunology, 97, 4, 1999. Crossref
-
Foss Dennis L., Murtaugh Michael P., Role of Macrophage Cytokines in Mucosal Adjuvanticity, in Veterinary Vaccines and Diagnostics, 41, 1999. Crossref
-
Glenn Gregory M, Flyer David C, Ellingsworth Larry R, Frech Sarah A, Frerichs David M, Seid Robert C, Yu Jianmei, Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch, Expert Review of Vaccines, 6, 5, 2007. Crossref
-
Petrovsky Nikolai, Aguilar Julio César, Vaccine adjuvants: Current state and future trends, Immunology & Cell Biology, 82, 5, 2004. Crossref
-
Lin Tong-Jun, Zhu Fu-Gang, Marshall jean s., Differential Regulation of Mast Cell Mediator Secretion by Bacterial Products, in Mast Cells and Basophils, 2000. Crossref
-
de Haan Lolke, Feil Ingeborg K., Verweij Willem R., Holtrop Marijke, Hol Wim G. J., Agsteribbe Etienne, Wilschut Jan, Mutational analysis of the role of ADP-ribosylation activity and GM1 -binding activity in the adjuvant properties of theEscherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin, European Journal of Immunology, 28, 4, 1998. Crossref
-
Maheshwari Chetan, Pandey R.S., Chaurasiya Akash, Kumar Ashu, Selvam D.T., Prasad G.B.K.S., Dixit V.K., Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B, International Immunopharmacology, 11, 10, 2011. Crossref
-
Fernandez-Miyakawa Mariano E., Brero Maria Luisa, Mateo Nancy A., Cholera Toxin Modulates the Systemic Immune Responses againstVibrio choleraeSurface Antigens after Repeated Inoculations, Microbiology and Immunology, 50, 8, 2006. Crossref
-
Glenn Gregory M, Scharton-Kersten Tanya, Alving Carl R, Advances in vaccine delivery: transcutaneous immunisation, Expert Opinion on Investigational Drugs, 8, 6, 1999. Crossref
-
Alcon Valeria, Baca-Estrada Maria, Vega-Lopez Marco, Willson Philip, Babiuk Lorne A., Kumar Praveen, Hecker Rolf, Foldvari Marianna, Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs, The AAPS Journal, 7, 3, 2005. Crossref
-
Foss Dennis L., Murtaugh Michael P., Mechanisms of vaccine adjuvanticity at mucosal surfaces, Animal Health Research Reviews, 1, 1, 2000. Crossref
-
McCluskie Michael J, Weeratna Risini D, Clements John D, Davis Heather L, Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants, Vaccine, 19, 27, 2001. Crossref
-
Kang Tae-Jin, Han So-Chon, Yang Moon-Sik, Jang Yong-Suk, Expression of synthetic neutralizing epitope of porcine epidemic diarrhea virus fused with synthetic B subunit of Escherichia coli heat-labile enterotoxin in tobacco plants, Protein Expression and Purification, 46, 1, 2006. Crossref
-
Cox John C., Coulter Alan R., Adjuvants—a classification and review of their modes of action, Vaccine, 15, 3, 1997. Crossref
-
Royaee Atabak R., Jong Linda, Mendis Chanaka, Das Rina, Jett Marti, Yang David C.H., Cholera toxin induced novel genes in human lymphocytes and monocytes, Molecular Immunology, 43, 8, 2006. Crossref
-
Kang Tae-Jin, Lee Won-Seok, Choi Eun-Gyung, Kim Jae-Whune, Kim Bang-Geul, Yang Moon-Sik, Mass production of somatic embryos expressing Escherichia coli heat-labile enterotoxin B subunit in Siberian ginseng, Journal of Biotechnology, 121, 2, 2006. Crossref
-
Ambrose Zandrea, Thompson Jannelle, Larsen Kay, Kuller Larene, Panicali Dennis L, Clements John D, Agy Michael, Montefiori David C, Hu Shiu-Lok, Bosch Marnix L, Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6, Virology, 308, 1, 2003. Crossref
-
Foss Dennis L, Murtaugh Michael P, Mucosal immunogenicity and adjuvanticity of cholera toxin in swine, Vaccine, 17, 7-8, 1999. Crossref
-
Bal Suzanne M., Ding Zhi, van Riet Elly, Jiskoot Wim, Bouwstra Joke A., Advances in transcutaneous vaccine delivery: Do all ways lead to Rome?, Journal of Controlled Release, 148, 3, 2010. Crossref
-
McEntee C., Lavelle E.C., O’Hagan D.T., Antigen Delivery Systems I, in Mucosal Immunology, 2015. Crossref
-
Ekström Jill, Hu Ke-Fei, Bengtsson Karin Lövgren, Morein Bror, Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions, Vaccine, 17, 20-21, 1999. Crossref
-
Glenn Gregory M, Kenney Richard T, Hammond Scott A, Ellingsworth Larry R, Transcutaneous immunization and immunostimulant strategies, Immunology and Allergy Clinics of North America, 23, 4, 2003. Crossref
-
Davitt Christopher J.H., Lavelle Ed C., Delivery strategies to enhance oral vaccination against enteric infections, Advanced Drug Delivery Reviews, 91, 2015. Crossref
-
Tebbey Paul W, Scheuer Catherine A, Peek Joel A, Zhu Duzhang, LaPierre Natisha A, Green Bruce A, Phillips Eric D, Ibraghimov Alexander R, Eldridge John H, Hancock Gerald E, Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H, Vaccine, 18, 24, 2000. Crossref
-
McCluskie Michael J, Davis Heather L, CpG DNA as mucosal adjuvant, Vaccine, 18, 3-4, 1999. Crossref
-
Kim Mi-Young, Kim Tae-Geum, Yoo Han-Sang, Yang Moon-Sik, Expression and assembly of ApxIIA toxin of Actinobacillus pleuropneumoniae fused with the enterotoxigenic E. coli heat-labile toxin B subunit in transgenic tobacco, Plant Cell, Tissue and Organ Culture (PCTOC), 105, 3, 2011. Crossref
-
Cheng Chunmei, Bettahi Ilham, Cruz-Fisher Maria I., Pal Sukumar, Jain Pooja, Jia Zhenyu, Holmgren Jan, Harandi Ali M., de la Maza Luis M., Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin, Vaccine, 27, 44, 2009. Crossref
-
Glueck Reinhard, Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization, Vaccine, 20, 2001. Crossref
-
Wu Hong-Yin, Russell Michael W., Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant, Vaccine, 16, 2-3, 1998. Crossref
-
Quéré Pascale, Girard Fabienne, Systemic adjuvant effect of cholera toxin in the chicken, Veterinary Immunology and Immunopathology, 70, 1-2, 1999. Crossref
-
Cusi M.G, Lomagistro M.M, Valassina M, Valensin P.E, Glück R, Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine, Vaccine, 18, 25, 2000. Crossref
-
Enioutina Elena Y., Bareyan Diana, Daynes Raymond A., Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties, Vaccine, 25, 7, 2007. Crossref
-
Kenney Richard T., Glenn Gregory M., Transcutaneous immunization using the heat-labile enterotoxin of E. coli as an adjuvant, in Immunopotentiators in Modern Vaccines, 2006. Crossref
-
Royaee Atabak R., Hammamieh Rasha, Mendis Chanaka, Das Rina, Jett Marti, H. Yang David C., Induction of immunomodulator transcriptional responses by cholera toxin, Molecular Immunology, 43, 7, 2006. Crossref
-
Tejada-Simon M.V., Lee J.H., Ustunol Z., Pestka J.J., Ingestion of Yogurt Containing Lactobacillus acidophilus and Bifidobacterium to Potentiate Immunoglobulin A Responses to Cholera Toxin in Mice, Journal of Dairy Science, 82, 4, 1999. Crossref
-
Hammond Scott A, Walwender Deborah, Alving Carl R, Glenn Gregory M, Transcutaneous immunization: T cell responses and boosting of existing immunity, Vaccine, 19, 17-19, 2001. Crossref
-
Braun Michael C., He Jianping, Wu Chang-You, Kelsall Brian L., Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor β1 and β2 Chain Expression , Journal of Experimental Medicine, 189, 3, 1999. Crossref
-
Murtaugh Michael P, Foss Dennis L, Inflammatory cytokines and antigen presenting cell activation, Veterinary Immunology and Immunopathology, 87, 3-4, 2002. Crossref
-
Vaccines in Theory and Practice, in Immunology for Pharmacy, 2012. Crossref
-
Huckriede Anke, Bungener Laura, Stegmann Toon, Daemen Toos, Medema Jeroen, Palache Abraham M., Wilschut Jan, The virosome concept for influenza vaccines, Vaccine, 23, 2005. Crossref
-
Verweij Willem R, Haan Lolke de, Holtrop Marijke, Agsteribbe Etienne, Brands Ruud, van Scharrenburg Guus J.M, Wilschut Jan, Musosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen, Vaccine, 16, 20, 1998. Crossref
-
Gaboriau-Routhiau Valérie, Moreau Marie-Christiane, Oral Tolerance to Ovalbumin in Mice: Induction and Long-Term Persistence Unaffected by Staphylococcus aureus Enterotoxin B and Clostridium perfringens Type A Enterotoxin, Pediatric Research, 42, 4, 1997. Crossref
-
Fischer Romy, McGhee Jerry R., Vu Huong Lan, Atkinson T. Prescott, Jackson Raymond J., Tomé Daniel, Boyaka Prosper N., Oral and Nasal Sensitization Promote Distinct Immune Responses and Lung Reactivity in a Mouse Model of Peanut Allergy, The American Journal of Pathology, 167, 6, 2005. Crossref
-
Morein Bror, Bengtsson Karin Lövgren, Immunomodulation by Iscoms, Immune Stimulating Complexes, Methods, 19, 1, 1999. Crossref
-
de Haan Aalzen, Van Scharrenburg Guus J.M., Masihi K. Noel, Wilschut Jan, Evaluation of a Liposome-Supplemented Intranasal Influenza Subunit Vaccine in a Murine Model System: Induction of Systemic and Local Mucosal Immunity, Journal of Liposome Research, 10, 2-3, 2000. Crossref
-
Davitt Christopher J.H., McNeela Edel A., Longet Stephanie, Tobias Joshua, Aversa Vincenzo, McEntee Craig P., Rosa Monica, Coulter Ivan S., Holmgren Jan, Lavelle Ed C., A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens, Journal of Controlled Release, 233, 2016. Crossref
-
Sahni Neha, Cheng Yuan, Middaugh C. Russell, Volkin David B., Vaccine Delivery, in Drug Delivery, 2016. Crossref
-
Snider Denis P., Liang Hong, Switzer Iain, Underdown Brian J., IgA production in MHC class II-deficient mice is primarily a function of B-1a cells, International Immunology, 11, 2, 1999. Crossref
-
Schmitt Clare K., Meysick Karen C., O'Brien Alison D., Bacterial Toxins: Friends or Foes?, Emerging Infectious Diseases, 5, 2, 1999. Crossref
-
Glück Reinhard, Intranasal Immunization against Influenza, Journal of Aerosol Medicine, 15, 2, 2002. Crossref
-
Kim Jung-Mi, Park Seung-Moon, Kim Jung-Ae, Park Jin-Ah, Yi Min-Hee, Kim Nan-Sun, Bae Jong-Lye, Park Sung Goo, Jang Yong-Suk, Yang Moon-Sik, Kim Dae-Hyuk, Functional Pentameric Formation via Coexpression of the Escherichia coli Heat-Labile Enterotoxin B Subunit and Its Fusion Protein Subunit with a Neutralizing Epitope of ApxIIA Exotoxin Improves the Mucosal Immunogenicity and Protection against Challenge by Actinobacillus pleuropneumoniae, Clinical and Vaccine Immunology, 18, 12, 2011. Crossref
-
Thoreux Karine, Schmucker Douglas Lees, Kefir Milk Enhances Intestinal Immunity in Young but Not Old Rats, The Journal of Nutrition, 131, 3, 2001. Crossref
-
Zauner Wolfgang, Lingnau Karen, Mattner Frank, Gabain Alexander von, Buschle Michael, Defined Synthetic Vaccines, Biological Chemistry, 382, 4, 2001. Crossref
-
Tarique A. A., Kalsy A., Arifuzzaman M., Rollins S. M., Charles R. C., Leung D. T., Harris J. B., LaRocque R. C., Sheikh A., Bhuiyan M. S., Saksena R., Clements J. D., Calderwood S. B., Qadri F., Kováč P., Ryan E. T., Transcutaneous Immunization with a Vibrio cholerae O1 Ogawa Synthetic Hexasaccharide Conjugate following Oral Whole-Cell Cholera Vaccination Boosts Vibriocidal Responses and Induces Protective Immunity in Mice, Clinical and Vaccine Immunology, 19, 4, 2012. Crossref
-
Rajendram Rajkumar, Preedy Victor, Hunter Ross, Cellular Effects of Bacterial Toxins, in Reviews in Food and Nutrition Toxicity, Volume 2, 20046445, 2004. Crossref
-
Glenn G. M., Kenney R. T., Mass Vaccination: Solutions in the Skin, in Mass Vaccination: Global Aspects — Progress and Obstacles, 304, 2006. Crossref
-
Glenn Gregory M., Taylor David N., Li Xiuru, Frankel Sarah, Montemarano Andrew, Alving Carl R., Transcutaneous immunization: A human vaccine delivery strategy using a patch, Nature Medicine, 6, 12, 2000. Crossref
-
Boirivant Monica, Fuss Ivan J., Ferroni Lucietta, De Pascale Mariateresa, Strober Warren, Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis, The Journal of Immunology, 166, 5, 2001. Crossref
-
Patton W. A., Vitale N., Moss J., Vaughan M., Mechanism of Cholera Toxin Action: ADP-Ribosylation Factors as Stimulators of Cholera Toxin-Catalyzed ADP-Ribosylation and Effectors in Intracellular Vesicular Trafficking Events, in Bacterial Protein Toxins, 2000. Crossref
-
Tanimoto Takeshi, Development of intranasal influenza vaccine, Drug Delivery System, 25, 1, 2010. Crossref
-
Croitoru K., Snider D., What determines the vigour of the immune response to Helicobacter pylori?, in Helicobacter pylori, 1996. Crossref
-
Zoeteweij J. Paul, Epperson Diane E., Porter Jackie D., Zhang Chen X., Frolova Olga Y., Constantinides Anita P., Fuhrmann Steven R., El-Amine Moustapha, Tian Jing-Hui, Ellingsworth Larry R., Glenn Gregory M., GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal Immunoadjuvant, The Journal of Immunology, 177, 2, 2006. Crossref
-
Alving Carl R., Matyas Gary R., Design and selection of vaccine adjuvants: principles and practice, in The Grand Challenge for the Future, 2005. Crossref
-
Hamlet A., Croitoru K., Overview of immune and inflammatory changes due to Helicobacter infection, in Helicobacter pylori, 2000. Crossref
-
Harokopakis E, Hajishengallis G, Greenway T E, Russell M W, Michalek S M, Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits, Infection and Immunity, 65, 4, 1997. Crossref
-
Wolf M K, Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli, Clinical Microbiology Reviews, 10, 4, 1997. Crossref
-
Moore R. N., Foss Dennis L., Zilliox Michael J., Murtaugh Michael P., Differential Regulation of Macrophage Interleukin-1 (IL-1), IL-12, and CD80-CD86 by Two Bacterial Toxins, Infection and Immunity, 67, 10, 1999. Crossref
-
Sultan Faisal, Jin Ling-ling, Jobling Michael G., Holmes Randall K., Stanley Samuel L., Mucosal Immunogenicity of a Holotoxin-Like Molecule Containing the Serine-Rich Entamoeba histolytica Protein (SREHP) Fused to the A 2 Domain of Cholera Toxin , Infection and Immunity, 66, 2, 1998. Crossref
-
Arce Sergio, Nawar Hesham F., Muehlinghaus Gwendolin, Russell Michael W., Connell Terry D., In Vitro Induction of Immunoglobulin A (IgA)- and IgM-Secreting Plasma Blasts by Cholera Toxin Depends on T-Cell Help and Is Mediated by CD154 Up-Regulation and Inhibition of Gamma Interferon Synthesis, Infection and Immunity, 75, 3, 2007. Crossref
-
Barbieri J. T., Millar Douglas G., Hirst Timothy R., Snider Denis P., Escherichia coli Heat-Labile Enterotoxin B Subunit Is a More Potent Mucosal Adjuvant than Its Closely Related Homologue, the B Subunit of Cholera Toxin , Infection and Immunity, 69, 5, 2001. Crossref
-
Petri W. A., Dunn Linda A., Upcroft Jacqueline A., Fowler Elizabeth V., Matthews Ben S., Upcroft Peter, Orally Administered Giardia duodenalis Extracts Enhance an Antigen-Specific Antibody Response , Infection and Immunity, 69, 10, 2001. Crossref
-
Clements J. D., Goetsch Liliane, Gonzalez Alexandra, Plotnicky-Gilquin Hélène, Haeuw Jean François, Aubry Jean Pierre, Beck Alain, Bonnefoy Jean Yves, Corvaı̈a Nathalie, Targeting of Nasal Mucosa-Associated Antigen-Presenting Cells In Vivo with an Outer Membrane Protein A Derived from Klebsiella pneumoniae , Infection and Immunity, 69, 10, 2001. Crossref
-
Moore R. N., Glenn Gregory M., Scharton-Kersten Tanya, Vassell Russell, Matyas Gary R., Alving Carl R., Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants, Infection and Immunity, 67, 3, 1999. Crossref
-
Glenn Gregory M., Villar Christina P., Flyer David C., Bourgeois A. Louis, McKenzie Robin, Lavker Robert M., Frech Sarah A., Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum Corneum , Infection and Immunity, 75, 5, 2007. Crossref
-
Burns D. L., Scharton-Kersten Tanya, Yu Jian-mei, Vassell Russell, O'Hagan Derek, Alving Carl R., Glenn Gregory M., Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants, Infection and Immunity, 68, 9, 2000. Crossref
-
Zhu Xinjun, Kahn Richard A., The Escherichia coli Heat Labile Toxin Binds to Golgi Membranes and Alters Golgi and Cell Morphologies Using ADP-ribosylation Factor-dependent Processes, Journal of Biological Chemistry, 276, 27, 2001. Crossref
-
McGhee J. R., Jiang Bo, Jordana Manel, Xing Zhou, Smaill Fionna, Snider Denis P., Borojevic Rajka, Steele-Norwood Darlene, Hunt Richard H., Croitoru Kenneth, Replication-Defective Adenovirus Infection Reduces Helicobacter felis Colonization in the Mouse in a Gamma Interferon- and Interleukin-12-Dependent Manner , Infection and Immunity, 67, 9, 1999. Crossref
-
Barbieri J. T., Martin Michael, Metzger Daniel J., Michalek Suzanne M., Connell Terry D., Russell Michael W., Comparative Analysis of the Mucosal Adjuvanticity of the Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb, Infection and Immunity, 68, 1, 2000. Crossref
-
Glenn Gregory M., Scharton-Kersten Tanya, Vassell Russell, Mallett Corey P., Hale Thomas L., Alving Carl R., Cutting Edge: Transcutaneous Immunization with Cholera Toxin Protects Mice Against Lethal Mucosal Toxin Challenge, The Journal of Immunology, 161, 7, 1998. Crossref